12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Serotonin neurotransmitter deficits are reported in suicide, major depressive disorder (MDD) and alcohol use disorder (AUD). To compare pathophysiology in these disorders, we mapped brain serotonin transporter (SERT), 5-HT 1A, and 5-HT 2A receptor binding throughout prefrontal cortex and in anterior cingulate cortex postmortem. Cases and controls died suddenly minimizing agonal effects and had a postmortem interval ≤24 h to avoid compromised brain integrity. Neuropathology and toxicology confirmed absence of neuropathology and psychotropic medications. For most subjects (167 of 232), a DSM-IV Axis I diagnosis was made by psychological autopsy. Autoradiography was performed in right hemisphere coronal sections at a pre-genual level. Linear model analyses included sex and age with group and Brodmann area as interaction terms. SERT binding was lower in suicides ( p = 0.004) independent of sex (females < males, p < 0.0001), however, the lower SERT binding was dependent on MDD diagnosis ( p = 0.014). Higher SERT binding was associated with diagnosis of alcoholism ( p = 0.012). 5-HT 1A binding was greater in suicides ( p < 0.001), independent of MDD ( p = 0.168). Alcoholism was associated with higher 5-HT 1A binding ( p < 0.001) but only in suicides ( p < 0.001). 5-HT 2A binding was greater in suicides ( p < 0.001) only when including MDD ( p = 0.117) and alcoholism ( p = 0.148) in the model. Reported childhood adversity was associated with higher SERT and 5-HT 1A binding ( p = 0.004) in nonsuicides and higher 5-HT 2A binding ( p < 0.001). Low SERT and more 5-HT 1A and 5-HT 2A binding in the neocortex in depressed suicides is dependent on Axis I diagnosis and reported childhood adversity. Findings in alcoholism differed from those in depression and suicide indicating a distinct serotonin system pathophysiology.

          Related collections

          Most cited references102

          • Record: found
          • Abstract: found
          • Article: not found

          Evolving knowledge of sex differences in brain structure, function, and chemistry.

          Clinical and epidemiologic evidence demonstrates sex differences in the prevalence and course of various psychiatric disorders. Understanding sex-specific brain differences in healthy individuals is a critical first step toward understanding sex-specific expression of psychiatric disorders. Here, we evaluate evidence on sex differences in brain structure, chemistry, and function using imaging methodologies, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), and structural magnetic resonance imaging (MRI) in mentally healthy individuals. MEDLINE searches of English-language literature (1980-November 2006) using the terms sex, gender, PET, SPECT, MRI, fMRI, morphometry, neurochemistry, and neurotransmission were performed to extract relevant sources. The literature suggests that while there are many similarities in brain structure, function, and neurotransmission in healthy men and women, there are important differences that distinguish the male from the female brain. Overall, brain volume is greater in men than women; yet, when controlling for total volume, women have a higher percentage of gray matter and men a higher percentage of white matter. Regional volume differences are less consistent. Global cerebral blood flow is higher in women than in men. Sex-specific differences in dopaminergic, serotonergic, and gamma-aminobutyric acid (GABA)ergic markers indicate that male and female brains are neurochemically distinct. Insight into the etiology of sex differences in the normal living human brain provides an important foundation to delineate the pathophysiological mechanisms underlying sex differences in neuropsychiatric disorders and to guide the development of sex-specific treatments for these devastating brain disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The neurobiology of suicide.

            The stress-diathesis model posits that suicide is the result of an interaction between state-dependent (environmental) stressors and a trait-like diathesis or susceptibility to suicidal behaviour, independent of psychiatric disorders. Findings from post-mortem studies of the brain and from genomic and in-vivo neuroimaging studies indicate a biological basis for this diathesis, indicating the importance of neurobiological screening and interventions, in addition to cognitive and mood interventions, in the prevention of suicide. Early-life adversity and epigenetic mechanisms might explain some of the link between suicide risk and brain circuitry and neurochemistry abnormalities. Results from a range of studies using diverse designs and post-mortem and in-vivo techniques show impairments of the serotonin neurotransmitter system and the hypothalamic-pituitary-adrenal axis stress-response system in the diathesis for suicidal behaviour. These impairments manifest as impaired cognitive control of mood, pessimism, reactive aggressive traits, impaired problem solving, over-reactivity to negative social signs, excessive emotional pain, and suicidal ideation, leading to suicidal behaviour. Biomarkers related to the diathesis might help to inform risk-assessment procedures and treatment choice in the prevention of suicide.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Aggression in humans correlates with cerebrospinal fluid amine metabolites

              Cerebrospinal fluid of the major central metabolites of serotonin (5HT), norepinephrine (NE), and dopamine (DA)--5-hydroxyindoleacetic acid (5HIAA), 3-methoxy-4-hydroxy=phenylglycol (MHPG), and homovanillic acid (HVA), respectively--were studied in a group of 26 age-similar military men with no history of major psychiatric illness, but with various personality disorders and difficulties adjusting to military life. Independently scored history of aggressive behavior showed a significant negative correlation with 5HIAA (r = -0.78) and a significant positive correlation with MHPG (r = 0.64).
                Bookmark

                Author and article information

                Contributors
                +646-774-7545 , mu20@cumc.columbia.edu
                Journal
                Transl Psychiatry
                Transl Psychiatry
                Translational Psychiatry
                Nature Publishing Group UK (London )
                2158-3188
                14 December 2018
                14 December 2018
                2018
                : 8
                : 279
                Affiliations
                [1 ]ISNI 0000000419368729, GRID grid.21729.3f, Department of Psychiatry, , Columbia University College of Physicians and Surgeons, ; New York, NY USA
                [2 ]ISNI 0000 0000 8499 1112, GRID grid.413734.6, Division of Molecular Imaging and Neuropathology, , Columbia University and New York State Psychiatric Institute, ; New York, NY USA
                [3 ]ISNI 0000 0000 8499 1112, GRID grid.413734.6, Division of Biostatistics, , Columbia University and New York State Psychiatric Institute, ; New York, NY USA
                [4 ]ISNI 0000000419368729, GRID grid.21729.3f, Department of Pathology and Cell Biology, , Columbia University College of Physicians and Surgeons, ; New York, NY USA
                [5 ]ISNI 0000 0001 2183 7908, GRID grid.419383.4, Macedonian Academy of Sciences and Arts, ; Skopje, Macedonia
                Author information
                http://orcid.org/0000-0002-1935-5982
                Article
                309
                10.1038/s41398-018-0309-1
                6294796
                30552318
                0aaff3ac-3f2a-477b-8253-bca8f4dcdd8c
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 26 July 2018
                : 5 August 2018
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000025, U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH);
                Award ID: MH40210
                Award ID: MH62185
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/100000027, U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA);
                Award ID: AA09004
                Award ID: AA11293
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/100000002, U.S. Department of Health & Human Services | National Institutes of Health (NIH);
                Award ID: MH90964
                Award ID: MH64168
                Award Recipient :
                Funded by: Dr. Mann receives royalties for the commercial use of the C-SSRS from the Research Foundation for Mental Hygiene.
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Clinical Psychology & Psychiatry
                Clinical Psychology & Psychiatry

                Comments

                Comment on this article